JSSH
DGX icon

J. Safra Sarasin Holding’s Quest Diagnostics DGX Stock Holding History

J. Safra Sarasin Holding’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,815
Closed -$3.97M – 518
2025
Q3 		$3.97M Buy
20,815
+7,627
+58% +$1.35M 0.06% 150
2025
Q2 		$2.37M Buy
13,188
+4,252
+48% +$739K 0.04% 194
2025
Q1 		$1.51M Sell
8,936
-6,766
-43% -$1.11M 0.03% 257
2024
Q4 		$2.37M Buy
15,702
+4,945
+46% +$769K 0.04% 211
2024
Q3 		$1.67M Sell
10,757
-337
-3% -$50.3K 0.03% 245
2024
Q2 		$1.52M Buy
+11,094
New +$1.52M 0.03% 275

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

J. Safra Sarasin Holding's DGX Position: Q4 2025 in Review

J. Safra Sarasin Holding sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 20,815 shares — an estimated $3.97M sold.

J. Safra Sarasin Holding first reported a position in DGX in Q2 2024 and held it in 6 quarters. The position peaked at $3.97M in Q3 2025. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • J. Safra Sarasin Holding reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • J. Safra Sarasin Holding sold 20,815 Quest Diagnostics shares in Q4 2025, an estimated $3.97M.
  • J. Safra Sarasin Holding first reported a position in Quest Diagnostics in Q2 2024 and held it in 6 quarters.
  • J. Safra Sarasin Holding's Quest Diagnostics position peaked at $3.97M in Q3 2025.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on J. Safra Sarasin Holding's 13F filing for Q4 2025, filed 15 Jan 2026.